BridgeMD
New treatment option for Sleep Apnea
Official title Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
ClinicalTrials.gov ID: NCT03860233
What this study is testing
What is Oxytocin?
Oxytocin is an investigational medicine, being studied as a potential treatment for sleep apnea.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study will investigate if an intra-nasal nose spray of the drug oxytocin can decrease the amount of pressure needed from the automatic Continuous Positive Airway Pressure (CPAP) device while sleeping decreasing some of the harmful effects of low oxygen in people with sleep apnea. This study will last 35 nights and involves spending three nights in the sleep lab at George Washington University.
- Phase 1: an early, usually small safety study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Men or women 18 years of age or older.
You likely can't join if
- people not willing to or otherwise unable to use CPAP for treatment of OSA.
- Presence of other sleep disorders
- Pregnant or breastfeeding women
- Women of child-bearing age (WOCBA) not willing or unable to use an accepted method to avoid pregnancy for the entire duration of the study
- Prisoners or people who are involuntarily incarcerated
- people who are compulsorily detain or treatment of either a psychiatric or physical (i.e. infectious disease) illness
See the full eligibility criteria
- Men or women 18 years of age or older.
- people not willing to or otherwise unable to use CPAP for treatment of OSA.
- Presence of other sleep disorders
- Pregnant or breastfeeding women
- Women of child-bearing age (WOCBA) not willing or unable to use an accepted method to avoid pregnancy for the entire duration of the study
- Prisoners or people who are involuntarily incarcerated
- people who are compulsorily detain or treatment of either a psychiatric or physical (i.e. infectious disease) illness
- Patients unable to give consent because of a language barrier, or other reason.
The study team makes the final eligibility decision.
Where it's taking place
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Washington D.C., District of Columbia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.